NARDONE, VALERIO
 Distribuzione geografica
Continente #
NA - Nord America 687
EU - Europa 171
AS - Asia 49
AF - Africa 9
SA - Sud America 5
OC - Oceania 4
Totale 925
Nazione #
US - Stati Uniti d'America 677
IT - Italia 57
IE - Irlanda 42
VN - Vietnam 22
FR - Francia 19
DE - Germania 18
CN - Cina 11
CA - Canada 10
GB - Regno Unito 10
SE - Svezia 10
JP - Giappone 7
NL - Olanda 6
ZA - Sudafrica 6
AU - Australia 4
CL - Cile 4
AT - Austria 2
RU - Federazione Russa 2
UG - Uganda 2
BR - Brasile 1
FI - Finlandia 1
GR - Grecia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
JO - Giordania 1
LT - Lituania 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
SA - Arabia Saudita 1
TN - Tunisia 1
TR - Turchia 1
UA - Ucraina 1
Totale 925
Città #
Fairfield 99
Ashburn 49
Seattle 47
Buffalo 46
Santa Cruz 42
Woodbridge 41
Dublin 40
Cambridge 30
Houston 27
Wilmington 26
Redmond 24
Dong Ket 21
Siena 20
Las Vegas 12
Boardman 11
Florence 10
Stockholm 10
Chicago 9
Clearwater 9
Riva 8
New York 7
Ottawa 7
Ann Arbor 6
Decatur 6
Los Angeles 6
Phoenix 6
San Diego 6
Southend 6
Ichibancho 5
Muizenberg 5
Pisa 5
Dallas 4
Shanghai 4
University Park 4
Columbus 3
Menlo Park 3
Reggio Calabria 3
Atlanta 2
Büdelsdorf 2
Council Bluffs 2
Easton 2
Kampala 2
Lake Forest 2
Munich 2
Nanjing 2
San Francisco 2
San Jose 2
Toronto 2
Aigaleo 1
Amman 1
Amsterdam 1
Anhui 1
Ankara 1
Auburn 1
Beijing 1
Bengaluru 1
Bologna 1
Bugiano 1
Cheyenne 1
Crotone 1
Crugers 1
Denver 1
Eindhoven 1
Frankfurt am Main 1
Giussano 1
Grumo Appula 1
Helsinki 1
Henderson 1
Ho Chi Minh City 1
Indiana 1
Jersey City 1
Johor Bahru 1
Leiden 1
Lincolnshire 1
Lombard 1
London 1
Macao 1
Manouba 1
Messina 1
Milpitas 1
Naaldwijk 1
Norwalk 1
Palermo 1
Portland 1
Providence 1
Recife 1
Reston 1
Rho 1
Rome 1
Saint Petersburg 1
Saitama 1
Salem 1
San Juan 1
Sarpsborg 1
Scranton 1
Secaucus 1
Shenyang 1
Shimonoseki 1
Silverton 1
Sydney 1
Totale 741
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients, file e0feeaa6-bb8b-44d2-e053-6605fe0a8db0 159
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine, file e0feeaa7-deba-44d2-e053-6605fe0a8db0 131
3D bone texture analysis as a potential predictor of radiationinduced insufficiency fractures, file e0feeaa7-2798-44d2-e053-6605fe0a8db0 128
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy, file e0feeaa6-a215-44d2-e053-6605fe0a8db0 121
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)., file e0feeaa7-6829-44d2-e053-6605fe0a8db0 120
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up, file e0feeaa8-4ca6-44d2-e053-6605fe0a8db0 96
Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: a case report, file e0feeaa8-cda7-44d2-e053-6605fe0a8db0 83
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT, file e0feeaab-cb3f-44d2-e053-6605fe0a8db0 38
null, file e0feeaa6-25a7-44d2-e053-6605fe0a8db0 26
Persistent hiccup after chemo-radiotherapy in nasopharyngeal cancer: an atypical side effect?, file e0feeaa6-27c5-44d2-e053-6605fe0a8db0 11
The combined EGFR protein expression analysis refines the prognostic value of the MGMT promoter methylation status in glioblastoma., file e0feeaa6-29bb-44d2-e053-6605fe0a8db0 11
Bone texture analysis using CT-simulation scans to individuate risk parameters for radiation-induced insufficiency fractures., file e0feeaa6-29bf-44d2-e053-6605fe0a8db0 11
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach, file fb9724f9-8cef-4316-a830-555819d967a8 8
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis, file ca371d2a-ec7a-485f-9b98-207f7ed9ecf5 5
Combined epidermal growth factor receptor and beclin1 autophagic protein expression analysis identifies different clinical presentations, responses to chemo- and radiotherapy, and prognosis in glioblastoma, file e0feeaa5-7dbb-44d2-e053-6605fe0a8db0 5
In Regard to Kubicek et al., file e0feeaa6-2afb-44d2-e053-6605fe0a8db0 5
Bone structure texture analysis as a potential tool to estimate radiation induced insufficiency fracture risk., file e0feeaa6-25a6-44d2-e053-6605fe0a8db0 4
Prognostic Value of MR Imaging Texture Analysis in Brain Non-Small Cell Lung Cancer Oligo-Metastases Undergoing Stereotactic Irradiation., file e0feeaa6-651b-44d2-e053-6605fe0a8db0 3
Perilesional edema in brain metastasis from non-small cell lung cancer (NSCLC) as predictor of response to radiosurgery (SRS), file e0feeaa6-2568-44d2-e053-6605fe0a8db0 2
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab, file e0feeaa7-92d0-44d2-e053-6605fe0a8db0 2
Texture analysis as a predictor of radiation-induced xerostomia in head and neck patients undergoing IMRT, file e0feeaaa-1032-44d2-e053-6605fe0a8db0 2
null, file e0feeaa6-2572-44d2-e053-6605fe0a8db0 1
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide., file e0feeaa6-7c45-44d2-e053-6605fe0a8db0 1
Totale 973
Categoria #
all - tutte 2.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201970 0 0 0 0 0 0 0 0 0 0 31 39
2019/2020197 15 10 7 25 16 16 24 20 25 19 7 13
2020/2021192 5 19 6 24 8 25 10 13 13 26 12 31
2021/2022178 9 27 6 6 16 3 10 12 3 6 62 18
2022/2023225 6 23 52 34 27 30 7 11 0 17 14 4
2023/202475 2 0 8 4 9 10 25 0 0 15 2 0
Totale 973